Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinal pigment epithelial (RPE) cell tight junctions are essential molecular complexes that form the outer blood-retinal barrier (oBRB), a selectively permeable barrier at the interface between the neural retina and the choroid. They are composed of claudins, occludin, junctional adhesion molecules (JAMs), and zonula occludens (ZO) proteins, and their dynamic regulation ensures proper retinal environment maintenance crucial for vision health. Disruption impairs this protective role, leading directly to disease processes affecting vision quality.
Modulation of tight junction protein expression/localization; alteration of signaling pathways regulating TJ integrity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal Pigment Epithelial Cell Tight Junctions (RPE Tight Junctions).